These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2283273)

  • 1. Ioxaglate-carrying liposomes. Computed tomographic study as hepatosplenic contrast agent in rabbits.
    Revel D; Corot C; Carrillon Y; Dandis G; Eloy R; Amiel M
    Invest Radiol; 1990 Sep; 25 Suppl 1():S95-7. PubMed ID: 2283273
    [No Abstract]   [Full Text] [Related]  

  • 2. Liposomes loaded with nonionic contrast media. Hepatosplenic computed tomographic enhancement.
    Passariello R; Pavone P; Patrizio G; Di Renzi P; Mastantuono M; Giuliani S
    Invest Radiol; 1990 Sep; 25 Suppl 1():S92-4. PubMed ID: 2283272
    [No Abstract]   [Full Text] [Related]  

  • 3. Contrast material-carrying liposomes: biodistribution, clearance, and imaging characteristics.
    Seltzer SE; Blau M; Herman LW; Hooshmand RL; Herman LA; Adams DF; Minchey SR; Janoff AS
    Radiology; 1995 Mar; 194(3):775-81. PubMed ID: 7862978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iopromide-carrying liposomes as a contrast agent for the liver.
    Krause W; Leike J; Schuhmann-Giampieri G; Sachse A; Schmiedl U; Strunk H
    Acad Radiol; 1996 Aug; 3 Suppl 2():S235-7. PubMed ID: 8796571
    [No Abstract]   [Full Text] [Related]  

  • 5. Brominated radiopaque liposomes: contrast agent for computed tomography of liver and spleen: a preliminary report.
    Caride VJ; Sostman HD; Twickler J; Zacharis H; Orphanoudakis SC; Jaffe CC
    Invest Radiol; 1982; 17(4):381-5. PubMed ID: 7129819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new procedure for contrast imaging of the liver and spleen using water-soluble contrast media in liposomes].
    Zerbin EA; Davidenkova EF; Chanson KP; Gubareva AV; Zdanova NV; Alijakparov MT; Losakova LV; Fomina EV; Rozenberg OA
    Radiol Diagn (Berl); 1983; 24(4):507-14. PubMed ID: 6635182
    [No Abstract]   [Full Text] [Related]  

  • 7. Perfluoroctylbromide and hepatosplenic computed tomography. Preliminary clinical study.
    Bruneton JN; Falewee MN; Balu-Maestro C; Normand F; Mattrey RF
    Invest Radiol; 1988 Sep; 23 Suppl 1():S306-7. PubMed ID: 3198367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and experimental evaluation of a contrast medium for computed tomographic examination of the liver and spleen.
    Vermess M; Chatterji DC; Doppman JL; Grimes G; Adamson RH
    J Comput Assist Tomogr; 1979 Feb; 3(1):25-31. PubMed ID: 217896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of liposomes carrying losefamate for CT opacification of liver and spleen.
    Seltzer SE; Shulkin PM; Adams DF; Davis MA; Hoey GB; Hopkins RM; Bosworth ME
    AJR Am J Roentgenol; 1984 Sep; 143(3):575-9. PubMed ID: 6331738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new liposomal contrast medium for CT of the liver. An imaging study in a rabbit tumour model.
    Leander P
    Acta Radiol; 1996 Jan; 37(1):63-8. PubMed ID: 8611327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanocrystalline computed tomography contrast agents for blood-pool and liver-spleen imaging.
    Gazelle GS; Wolf GL; Bacon ER; McIntire GL; Cooper ER; Toner JL
    Invest Radiol; 1994 Jun; 29 Suppl 2():S286-8. PubMed ID: 7928258
    [No Abstract]   [Full Text] [Related]  

  • 12. Computed tomographic enhancement of the liver, liver abscesses, spleen, and major vessels with perfluorooctylbromide emulsion. Influence of dosage and injection velocity in an animal model.
    Adam G; Günther RW; Schiffer C; Görtz H; Prescher A; Scherer K
    Invest Radiol; 1992 Sep; 27(9):698-705. PubMed ID: 1399453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particulate contrast medium for computed tomography of the liver.
    Gjøen T; Strande P; Golman K; Klaveness J; Leander P; Aulie Michelet A
    Invest Radiol; 1990 Sep; 25 Suppl 1():S98-9. PubMed ID: 2283274
    [No Abstract]   [Full Text] [Related]  

  • 14. Nanoparticulate computed tomography contrast agents for blood pool and liver-spleen imaging.
    Gazelle GS; Wolf GL; McIntire GL; Bacon ER; Halpern EF; Cooper ER; Toner JL
    Acad Radiol; 1994 Dec; 1(4):373-6. PubMed ID: 9419514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new contrast material for CT of the liver and spleen. Iodinated oil emulsified by a non-ionic contrast material].
    Hori S; Murakami T; Nishikawa M; Fujita N; Hashimoto T; Kozuka T; Narumi Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Dec; 48(12):1503-10. PubMed ID: 2855110
    [No Abstract]   [Full Text] [Related]  

  • 16. Nanoparticulate contrast media. Blood-pool and liver-spleen imaging.
    Rubin DL; Desser TS; Qing F; Muller HH; Young SW; McIntire GL; Bacon E; Cooper E; Toner J
    Invest Radiol; 1994 Jun; 29 Suppl 2():S280-3. PubMed ID: 7928256
    [No Abstract]   [Full Text] [Related]  

  • 17. A liposomal contrast agent. Preliminary communication.
    Musu C; Felder E; Lamy B; Schneider M
    Invest Radiol; 1988 Sep; 23 Suppl 1():S126-9. PubMed ID: 3198331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfluoroctylbromide: a reticuloendothelial-specific and tumor-imaging agent for computed tomography.
    Mattrey RF; Long DM; Multer F; Mitten R; Higgins CB
    Radiology; 1982 Dec; 145(3):755-8. PubMed ID: 7146408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT blood pool enhancement in primates with lopromide-carrying liposomes containing soy phosphatidyl glycerol.
    Schmiedl UP; Krause W; Leike J; Sachse A
    Acad Radiol; 1999 Mar; 6(3):164-9. PubMed ID: 10898035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The production and evaluation of contrast-carrying liposomes made with an automatic high-pressure system.
    Cheng KT; Seltzer SE; Adams DF; Blau M
    Invest Radiol; 1987 Jan; 22(1):47-55. PubMed ID: 3818235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.